| abstract |
The invention relates to a vaccine composition comprising:n a) inactivated whole virus, and b) a stabilizing excipient which comprises:n i. a buffer solution, ii. a mixture of essential and nonessential amino acids, iii. a disaccharide, iv. a polyol, v. a chelating agent, vi. urea or a urea derivative, and vii. a nonionic surfactant. |